SQM (NYSE: SQM) to double Mt Holland lithium output with expansion
Rhea-AI Filing Summary
Sociedad Química y Minera de Chile (SQM), together with partner Wesfarmers, has approved the final investment decision to expand the Mt Holland lithium project, adding mine, concentrator and integrated ore-sorting capacity. The plan will double nameplate spodumene concentrate production from approximately 380,000 tonnes per year to 760,000 tonnes of lithium concentrate at 5.5% Li₂O per year on a 100 per cent basis.
Construction of a second concentrator is expected to begin in the second half of 2027, with first spodumene concentrate volumes from the expansion expected in the first half of 2030. SQM’s share of capital expenditure is estimated between US$450 million and US$500 million in nominal terms. Required government and regulatory approvals have either been secured or are underway.
Positive
- Mt Holland lithium expansion doubles capacity, increasing nameplate spodumene concentrate output from about 380,000 to 760,000 tonnes per year, with SQM committing US$450–500 million alongside partner Wesfarmers.
Negative
- None.
Filing Explained
SQM’s stated expansion capital share excludes life-of-mine spending, and expanded output has no single disclosed downstream destination.
The approved expansion is still pre-construction, and SQM's disclosed
The filing also leaves the expanded production route open: it describes supply to any future potential Kwinana refinery expansion or sale as spodumene concentrate, rather than a committed allocation.
Key Figures
SQM capex share (low end): US$450 million
SQM capex share (high end): US$500 million
Current nameplate production: 380,000 tonnes per year
+4 more
7 metrics
SQM capex share (low end)
US$450 million
Estimated share of capital expenditure for the Mt Holland expansion in nominal terms
SQM capex share (high end)
US$500 million
Upper end of estimated capital expenditure range for the expansion
Current nameplate production
380,000 tonnes per year
Approximate existing spodumene concentrate nameplate output before expansion
Post-expansion nameplate production
760,000 tonnes per year
Target lithium concentrate capacity at 5.5% Li₂O on a 100 per cent basis
Lithium concentrate grade
5.5% Li₂O
Grade of spodumene concentrate for the expanded nameplate capacity
Construction start
Second half of 2027
Expected commencement of construction of the second concentrator
First expansion production
First half of 2030
Expected timing of first spodumene concentrate volumes from the expansion
Key Terms
spodumene concentrate, definitive feasibility study, nameplate spodumene concentrate production, downstream processing, +1 more
5 terms
spodumene concentrate technical
"will double spodumene concentrate production and lower unit operating costs"
A processed rock product that concentrates spodumene, a mineral rich in lithium, which is then refined into lithium chemicals used to make rechargeable batteries. Think of it as the crude oil equivalent for lithium batteries: an early-stage raw material whose availability and price influence the cost and supply of battery-grade lithium. Investors watch spodumene concentrate as an indicator of future battery material supply, production costs, and the health of electric-vehicle and energy-storage supply chains.
definitive feasibility study financial
"Covalent Lithium ... has completed a definitive feasibility study for the expansion"
A definitive feasibility study is a detailed, near-final assessment that shows whether a proposed project—often a mine, infrastructure or major industrial venture—can be built and operated profitably. It combines precise engineering plans, realistic cost estimates, production schedules and risk analysis to give lenders and investors a clear picture of expected returns and potential pitfalls, like a full blueprint and budget that helps decide whether to greenlight financing and construction.
nameplate spodumene concentrate production technical
"increase nameplate spodumene concentrate production from approximately 380,000 tonnes"
downstream processing technical
"optionalitiy to supply any future potential expansion of downstream processing at Covalent"
Downstream processing is the set of manufacturing steps that take place after a biological product is made, where the target molecule is separated, cleaned and turned into a stable, usable drug or vaccine form. It matters to investors because these steps determine how much usable product is recovered, how quickly regulators will accept it, and how costly manufacturing will be—like turning raw crops into packaged food, small losses or contamination can sharply affect supply, timelines and profits.
lithium concentrate at 5.5% Li₂O technical
"760,000 tonnes of lithium concentrate at 5.5% Li₂O per year"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What expansion decision did SQM (SQM) and Wesfarmers make for the Mt Holland lithium project?
They jointly approved a final investment decision to expand the Mt Holland lithium project. The plan adds mine, concentrator and ore-sorting capacity and will double nameplate spodumene concentrate production to 760,000 tonnes per year at 5.5% Li₂O on a 100 per cent basis.
How much new lithium production capacity will the Mt Holland expansion add for SQM (SQM)?
The expansion will increase nameplate spodumene concentrate production from approximately 380,000 to 760,000 tonnes per year. This represents a doubling of output for lithium concentrate at 5.5% Li₂O, on a 100 per cent project basis through Covalent Lithium.
What capital expenditure will SQM (SQM) commit to the Mt Holland expansion?
SQM estimates its share of capital expenditure for the Mt Holland expansion at US$450 million to US$500 million in nominal terms. This spending relates to the mine, concentrator, integrated ore-sorting facility and associated project expansion works at Mt Holland.
When does SQM (SQM) expect construction and first production from the Mt Holland expansion?
Construction of the second concentrator is expected to start in the second half of 2027. First spodumene concentrate production volumes from the expansion are expected in the first half of 2030, following completion and ramp-up of the new facilities.
What role does Covalent Lithium play in SQM’s (SQM) Mt Holland expansion?
Covalent Lithium, the joint venture owned by SQM and Wesfarmers, completed the definitive feasibility study for the expansion. It operates the integrated Mt Holland business, including the mine, concentrator and potential downstream processing via the Kwinana refinery.
How will the Mt Holland expansion support future downstream processing for SQM (SQM)?
The expansion provides optionality to supply future downstream processing at Covalent Lithium’s Kwinana refinery or to sell expanded volumes as spodumene concentrate. This gives flexibility in how increased production is commercialised as lithium demand grows.